Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity

AIMS: Myocarditis is often associated with parvovirus B19 (B19V) persistence, which can induce vascular damage. Based on the antiviral and anti‐inflammatory properties of telbivudine, we aimed to evaluate its efficacy to protect B19V‐infected endothelial cells in vitro and to treat chronic lymphocyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Linthout, Sophie, Elsanhoury, Ahmed, Klein, Oliver, Sosnowski, Marzena, Miteva, Kapka, Lassner, Dirk, Abou‐El‐Enein, Mohamed, Pieske, Burkert, Kühl, Uwe, Tschöpe, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165949/
https://www.ncbi.nlm.nih.gov/pubmed/30099854
http://dx.doi.org/10.1002/ehf2.12341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165949/
https://www.ncbi.nlm.nih.gov/pubmed/30099854
http://dx.doi.org/10.1002/ehf2.12341

Ejemplares similares